Document is current
Any future updates will be listed below
-
Authors
Ho, Ada Man-Choi https://orcid.org/0000-0003-4989-8782
Coombes, Brandon J. https://orcid.org/0000-0003-4322-5923
Batzler, Anthony
Pazdernik, Vanessa K. https://orcid.org/0000-0001-7566-7334
Pendegraft, Richard S.
Skime, Michelle https://orcid.org/0000-0001-7863-3017
Bendjemaa, Narjes
Carpiniello, Bernardo
Contu, Martina
Dalkner, Nina
Fellendorf, Frederike T. https://orcid.org/0000-0001-7215-3848
Fico, Giovanna https://orcid.org/0000-0003-1785-7126
Fullerton, Claudio D.
Gardea-Resendez, Manuel https://orcid.org/0000-0002-9825-8792
Gonzalez-Garza, Sarai
Jaafari, Nematollah
Jiménez, Esther
Kebir, Oussama
Legrand, Adrien
Luna-Garza, Sofia https://orcid.org/0000-0002-5599-0043
Meloni, Anna
Millet, Bruno
Mouaffak, Fayçal
Nunes, Abraham https://orcid.org/0000-0002-4955-9150
O’Donovan, Claire
Paribello, Pasquale
Pinna, Marco
Pisanu, Claudia https://orcid.org/0000-0002-9151-4319
Pomarol-Clotet, Edith
Romo-Nava, Francisco https://orcid.org/0000-0002-5894-3701
Sánchez, Raúl F.
Scott, Katie https://orcid.org/0000-0001-5395-5036
Squassina, Alessio
Vilella, Elisabet https://orcid.org/0000-0002-1887-5919
Serretti, Alessandro https://orcid.org/0000-0003-4363-3759
Prieto, Miguel L. https://orcid.org/0000-0001-5578-4605
Reininghaus, Eva Z. https://orcid.org/0000-0001-5964-4087
Bengesser, Susanne A.
Cuellar-Barboza, Alfredo B.
Krebs, Marie-Odile https://orcid.org/0000-0002-4715-9890
Chaumette, Boris https://orcid.org/0000-0002-1313-2788
Vieta, Eduard https://orcid.org/0000-0002-0548-0053
Manchia, Mirko https://orcid.org/0000-0003-4175-6413
McElroy, Susan L.
Alda, Martin https://orcid.org/0000-0001-9544-3944
Frye, Mark A.
Biernacka, Joanna M. https://orcid.org/0000-0001-9350-4440
- License Information
-
More Information
Article History
Received: 22 March 2025
Revised: 28 December 2025
Accepted: 30 January 2026
First Online: 19 February 2026
Competing interests
: EV has received grants and served as consultant, advisor or CME speaker for the following entities: AB-Biotics, AbbVie, Adamed, Alcediag, Angelini, Biogen, Beckley-Psytech, Biohaven, Boehringer-Ingelheim, Celon Pharma, Compass, Dainippon Sumitomo Pharma, Ethypharm, Ferrer, Gedeon Richter, GH Research, Glaxo-Smith Kline, HMNC, Idorsia, Johnson & Johnson, Lundbeck, Luye Pharma, Medincell, Merck, Newron, Novartis, Orion Corporation, Organon, Otsuka, Roche, Rovi, Sage, Sanofi-Aventis, Sunovion, Takeda, Teva, and Viatris, outside the submitted work. SLM is a consultant to, or member of the scientific advisory boards, in the past year: Axsome, Idorsia, Kallyope, Levo. Novo Nordisk, and Soleno; and is presently or has been in the past year a principal or co-investigator on research studies sponsored by: Axsome and Marriott Foundation. She is also inventor on United States Patent No. 6,323,236 B2, Use of Sulfamate Derivatives for Treating Impulse Control Disorders, and, along with the patent’s assignee, University of Cincinnati, Cincinnati, OH, has received payments from Johnson & Johnson Pharmaceutical Research & Development, L.L.C., which has exclusive rights under the patent. All other authors have no conflicts of interest in relation to this work to declare.
